收费全文 | 242篇 |
免费 | 26篇 |
国内免费 | 1篇 |
财政金融 | 46篇 |
工业经济 | 33篇 |
计划管理 | 63篇 |
经济学 | 25篇 |
综合类 | 30篇 |
旅游经济 | 3篇 |
贸易经济 | 33篇 |
农业经济 | 29篇 |
经济概况 | 7篇 |
2024年 | 2篇 |
2023年 | 3篇 |
2022年 | 9篇 |
2021年 | 11篇 |
2020年 | 7篇 |
2019年 | 5篇 |
2018年 | 10篇 |
2017年 | 4篇 |
2016年 | 16篇 |
2015年 | 3篇 |
2014年 | 15篇 |
2013年 | 16篇 |
2012年 | 12篇 |
2011年 | 22篇 |
2010年 | 13篇 |
2009年 | 13篇 |
2008年 | 17篇 |
2007年 | 16篇 |
2006年 | 15篇 |
2005年 | 8篇 |
2004年 | 9篇 |
2003年 | 6篇 |
2002年 | 8篇 |
2001年 | 3篇 |
2000年 | 4篇 |
1999年 | 8篇 |
1998年 | 5篇 |
1997年 | 2篇 |
1996年 | 1篇 |
1994年 | 3篇 |
1993年 | 1篇 |
1984年 | 1篇 |
1978年 | 1篇 |
Materials and methods: This pharmacoeconomic study was developed from the perspective of the Brazilian Public Healthcare System. The new strategy proposes using an amino acid formula in the diagnostic elimination diet of infants (≤24 months) with suspected CMA. The rationale is that infants who do not respond to the amino acid formula do not suffer from CMA. Patients with a positive oral challenge test receive a therapeutic elimination diet based on Brazilian Food Allergy Guidelines. This approach was compared to the current recommendations of the Brazilian Food Allergy Guidelines. A decision model was constructed using TreeAge Pro 2012 software. Model inputs were based on a literature review and the opinions of a panel of experts. A univariate sensitivity analysis of incremental cost-effectiveness ratios was performed.
Results: The mean cost per patient of the new amino acid formula strategy was R$3,341.57, while the cost of the current Brazilian guidelines strategy was R$3,641.08. The mean number of symptom-free days per patient, which was used as an indicator of effectiveness, was 900.6 and 875.7 days, respectively. The new strategy is, therefore, dominant. In the sensitivity analysis, the dominance was maintained with parameter variation.
Limitations: In the absence of information in the literature, some premises were defined by a panel of specialists.
Conclusions: The new strategy, which uses an amino acid formula in the elimination diagnostic diet followed by an oral food challenge, is a dominant pharmacoeconomic approach that has a lower cost and results in an increased number of symptom-free days. 相似文献